Thomas Jefferson University

Brian Swanson

TitleAdjunct Faculty Nonexempt
InstitutionThomas Jefferson University
DepartmentAdministration - Thomas Jefferson University
Address1101 Market
Philadelphia PA
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Bachert C, Laidlaw TM, Cho SH, Mullol J, Swanson BN, Naimi S, Classe M, Harel S, Jagerschmidt A, Laws E, Ruddy M, Praestgaard A, Amin N, Mannent LP. Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results. Ann Otol Rhinol Laryngol. 2023 Jun 15; 34894231176334. PMID: 37322842.
      Citations:    
    2. Hamilton JD, Harel S, Swanson BN, Brian W, Chen Z, Rice MS, Amin N, Ardeleanu M, Radin A, Shumel B, Ruddy M, Patel N, Pirozzi G, Mannent L, Graham NMH. Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases. Clin Exp Allergy. 2021 07; 51(7):915-931. PMID: 34037993.
      Citations:    
    3. Li Z, Radin A, Li M, Hamilton JD, Kajiwara M, Davis JD, Takahashi Y, Hasegawa S, Ming JE, DiCioccio AT, Li Y, Kovalenko P, Lu Q, Ortemann-Renon C, Ardeleanu M, Swanson BN. Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Dupilumab in Healthy Adult Subjects. Clin Pharmacol Drug Dev. 2020 08; 9(6):742-755. PMID: 32348036.
      Citations:    
    4. Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson K, Chehade M, Schoepfer AM, Safroneeva E, Rothenberg ME, Falk GW, Assouline-Dayan Y, Zhao Q, Chen Z, Swanson BN, Pirozzi G, Mannent L, Graham NMH, Akinlade B, Stahl N, Yancopoulos GD, Radin A. Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis. Gastroenterology. 2020 01; 158(1):111-122.e10. PMID: 31593702.
      Citations:    
    5. Bachert C, Hellings PW, Mullol J, Naclerio RM, Chao J, Amin N, Grabher A, Swanson BN, Hamilton JD, Guillonneau S, Taniou C, Zhang D, Pirozzi G, Graham NMH, Staudinger H, Mannent LP, Khan A. Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2447-2449.e2. PMID: 30928658.
      Citations:    
    6. Jonstam K, Swanson BN, Mannent LP, Cardell LO, Tian N, Wang Y, Zhang D, Fan C, Holtappels G, Hamilton JD, Grabher A, Graham NMH, Pirozzi G, Bachert C. Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis. Allergy. 2019 04; 74(4):743-752. PMID: 30488542.
      Citations:    
    7. Guttman-Yassky E, Bissonnette R, Ungar B, Su?rez-Fari?as M, Ardeleanu M, Esaki H, Suprun M, Estrada Y, Xu H, Peng X, Silverberg JI, Menter A, Krueger JG, Zhang R, Chaudhry U, Swanson B, Graham NMH, Pirozzi G, Yancopoulos GD, D Hamilton JD. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. J Allergy Clin Immunol. 2019 01; 143(1):155-172. PMID: 30194992.
      Citations:    
    8. Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, Busse WW, Ford L, Sher L, FitzGerald JM, Katelaris C, Tohda Y, Zhang B, Staudinger H, Pirozzi G, Amin N, Ruddy M, Akinlade B, Khan A, Chao J, Martincova R, Graham NMH, Hamilton JD, Swanson BN, Stahl N, Yancopoulos GD, Teper A. Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma. N Engl J Med. 2018 06 28; 378(26):2486-2496. PMID: 29782217.
      Citations:    
    9. Rabe KF, Nair P, Brusselle G, Maspero JF, Castro M, Sher L, Zhu H, Hamilton JD, Swanson BN, Khan A, Chao J, Staudinger H, Pirozzi G, Antoni C, Amin N, Ruddy M, Akinlade B, Graham NMH, Stahl N, Yancopoulos GD, Teper A. Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma. N Engl J Med. 2018 06 28; 378(26):2475-2485. PMID: 29782224.
      Citations:    
    10. Davis JD, Bansal A, Hassman D, Akinlade B, Li M, Li Z, Swanson B, Hamilton JD, DiCioccio AT. Evaluation of Potential Disease-Mediated Drug-Drug Interaction in Patients With Moderate-to-Severe Atopic Dermatitis Receiving Dupilumab. Clin Pharmacol Ther. 2018 12; 104(6):1146-1154. PMID: 29498038.
      Citations:    
    11. Reyes-Soffer G, Pavlyha M, Ngai C, Thomas T, Holleran S, Ramakrishnan R, Karmally W, Nandakumar R, Fontanez N, Obunike J, Marcovina SM, Lichtenstein AH, Matthan NR, Matta J, Maroccia M, Becue F, Poitiers F, Swanson B, Cowan L, Sasiela WJ, Surks HK, Ginsberg HN. Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans. Circulation. 2017 Jan 24; 135(4):352-362. PMID: 27986651.
      Citations:    
    12. Bachert C, Mannent L, Naclerio RM, Mullol J, Ferguson BJ, Gevaert P, Hellings P, Jiao L, Wang L, Evans RR, Pirozzi G, Graham NM, Swanson B, Hamilton JD, Radin A, Gandhi NA, Stahl N, Yancopoulos GD, Sutherland ER. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial. JAMA. 2016 Feb 02; 315(5):469-79. PMID: 26836729.
      Citations:    
    13. Liao WC, Vesterqvist O, Delaney C, Jemal M, Ferreira I, Ford N, Swanson B, Uderman H. Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor, omapatrilat in healthy subjects. Br J Clin Pharmacol. 2003 Oct; 56(4):395-406. PMID: 12968984.
      Citations:    
    14. Swanson BN. Delivery of high-quality biomarker assays. Dis Markers. 2002; 18(2):47-56. PMID: 12364810.
      Citations:    
    15. Triscari J, Swanson BN, Willard DA, Cohen AI, Devault A, Pan HY. Steady state serum concentrations of pravastatin and digoxin when given in combination. Br J Clin Pharmacol. 1993 Sep; 36(3):263-5. PMID: 9114914.
      Citations:    
    16. Pan HY, Triscari J, DeVault AR, Smith SA, Wang-Iverson D, Swanson BN, Willard DA. Pharmacokinetic interaction between propranolol and the HMG-CoA reductase inhibitors pravastatin and lovastatin. Br J Clin Pharmacol. 1991 Jun; 31(6):665-70. PMID: 1907839.
      Citations:    
    17. Pan HY, DeVault AR, Wang-Iverson D, Ivashkiv E, Swanson BN, Sugerman AA. Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin. J Clin Pharmacol. 1990 Dec; 30(12):1128-35. PMID: 2125605.
      Citations:    
    18. Vlasses PH, Rotmensch HH, Swanson BN, Clementi RA, Ferguson RK. Effect of repeated doses of L-5-hydroxytryptophan and carbidopa on prolactin and aldosterone secretion in man. J Endocrinol Invest. 1989 Feb; 12(2):87-91. PMID: 2474017.
      Citations:    
    19. Fruncillo RJ, Swanson BN, Bernhard R, Marchion C, Ferguson RK. Effect of renal failure or biliary stasis on the pharmacokinetics of amiodarone in the rat. J Pharm Sci. 1986 Feb; 75(2):150-4. PMID: 3958923.
      Citations:    
    20. Mojaverian P, Rocci ML, Swanson BN, Vlasses PH, Chremos AN, Lin JH, Yeh JC, Ferguson RK. Steady-state disposition of diflunisal: once- versus twice-daily administration. Pharmacotherapy. 1985 Nov-Dec; 5(6):336-9. PMID: 3841206.
      Citations:    
    21. Fruncillo RJ, Bernhard R, Swanson BN, Vlasses PH, Ferguson RK. Effect of phenobarbitone on the pharmacokinetics and tissue levels of amiodarone in the rat. J Pharm Pharmacol. 1985 Oct; 37(10):729-31. PMID: 2867144.
      Citations:    
    22. Riley LJ, Vlasses PH, Rotmensch HH, Swanson BN, Chremos AN, Johnson CL, Ferguson RK. Sulindac and ibuprofen inhibit furosemide-stimulated renin release but not natriuresis in men on a normal sodium diet. Nephron. 1985; 41(3):283-8. PMID: 3903529.
      Citations:    
    23. Fruncillo RJ, Rotmensch HH, Vlasses PH, Koplin JR, Swanson BN, Ferguson RK. Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives. Eur J Clin Pharmacol. 1985; 28(1):5-9. PMID: 3886401.
      Citations:    
    24. Swanson BN, Vlasses PH, Ferguson RK, Bergquist PA, Till AE, Irvin JD, Harris K. Influence of food on the bioavailability of enalapril. J Pharm Sci. 1984 Nov; 73(11):1655-7. PMID: 6097665.
      Citations:    
    25. Rotmensch HH, Belhassen B, Swanson BN, Shoshani D, Spielman SR, Greenspon AJ, Greenspan AM, Vlasses PH, Horowitz LN. Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity. Ann Intern Med. 1984 Oct; 101(4):462-9. PMID: 6476633.
      Citations:    
    26. Fedder IL, Vlasses PH, Mojaverian P, Rocci ML, Rotmensch HH, Swanson BN, Ferguson RK. Relationship of morphine-induced miosis to plasma concentration in normal subjects. J Pharm Sci. 1984 Oct; 73(10):1496-7. PMID: 6502506.
      Citations:    
    27. Vlasses PH, Rotmensch HH, Swanson BN, Irvin JD, Johnson CL, Ferguson RK. Indacrinone: natriuretic and uricosuric effects of various ratios of its enantiomers in healthy men. Pharmacotherapy. 1984 Sep-Oct; 4(5):272-7. PMID: 6504708.
      Citations:    
    28. Rotmensch HH, Rocci ML, Vlasses PH, Swanson BN, Fedder IL, Soyka L, Ferguson RK. Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension. Am J Cardiol. 1984 Aug 01; 54(3):353-6. PMID: 6147080.
      Citations:    
    29. May CA, Vlasses PH, Rocci ML, Rotmensch HH, Swanson BN, Tannenbaum RP, Ferguson RK, Abrams WB. Methyldopa does not alter the disposition of digoxin. J Clin Pharmacol. 1984 Aug-Sep; 24(8-9):386-9. PMID: 6480880.
      Citations:    
    30. Rotmensch HH, Vincent M, Vlasses PH, Swanson BN, Irvin JD, Hichens M, Harris KE, Ferguson RK. Initial evaluation of the non-sulfhydryl-containing converting enzyme inhibitor MK-521 in hypertensive humans. Fed Proc. 1984 Apr; 43(5):1333-5. PMID: 6323225.
      Citations:    
    31. Mojaverian P, Swanson BN, Ferguson RK. Enalapril, a new nonsulfhydryl angiotensin converting enzyme inhibitor, does not potentiate morphine analgesia. Eur J Pharmacol. 1984 Feb 17; 98(2):303-6. PMID: 6325220.
      Citations:    
    32. Vincent ME, Swanson BN, Shepley K, Ferguson RK. Hemodynamic and humoral responses to enalapril and nifedipine in the rat. Clin Exp Hypertens A. 1984; 6(8):1485-97. PMID: 6094050.
      Citations:    
    33. Rotmensch HH, Vlasses PH, Swanson BN, Irvin JD, Harris KE, Merrill DG, Ferguson RK. Antihypertensive efficacy of once daily MK-521, a new nonsulfhydryl angiotensin-converting enzyme inhibitor. Am J Cardiol. 1984 Jan 01; 53(1):116-9. PMID: 6318543.
      Citations:    
    34. Rotmensch HH, Swanson BN, Greenspon AJ, Shoshani D, Greenspan AM. Amiodarone: individualizing dosage with serum concentrations. Pacing Clin Electrophysiol. 1983 Nov; 6(6):1327-35. PMID: 6196742.
      Citations:    
    35. Swanson BN, Mojaverian P, Boppana VK. Inhibition of sulindac metabolism by dimethyl sulfoxide in the rat. J Toxicol Environ Health. 1983 Aug-Sep; 12(2-3):213-22. PMID: 6655731.
      Citations:    
    36. Rotmensch HH, Vlasses PH, Carpenter KL, D'Amelio LF, Swanson BN, Ferguson RK. Plasma platelet products and exercise-induced myocardial ischemia. J Lab Clin Med. 1983 Jul; 102(1):63-9. PMID: 6854135.
      Citations:    
    37. Swanson BN, Boppana VK, Vlasses PH, Rotmensch HH, Ferguson RK. Dimethyl sulfoxide inhibits bioactivation of sulindac. J Lab Clin Med. 1983 Jul; 102(1):95-101. PMID: 6854139.
      Citations:    
    38. Vlasses PH, Ferguson RK, Smith JB, Rotmensch HH, Swanson BN. Urinary excretion of prostacyclin and thromboxane A2 metabolites after angiotensin converting enzyme inhibition in hypertensive patients. Prostaglandins Leukot Med. 1983 Jun; 11(2):143-50. PMID: 6308685.
      Citations:    
    39. Swanson BN, Ferguson RK, Raskin NH, Wolf BA. Peripheral neuropathy after concomitant administration of dimethyl sulfoxide and sulindac. Arthritis Rheum. 1983 Jun; 26(6):791-3. PMID: 6305373.
      Citations:    
    40. Vlasses PH, Rotmensch HH, Swanson BN, Irvin JD, Lee RB, Koplin JR, Ferguson RK. Comparative antihypertensive effects of enalapril maleate and hydrochlorothiazide, alone and in combination. J Clin Pharmacol. 1983 May-Jun; 23(5-6):227-33. PMID: 6308068.
      Citations:    
    41. Swanson BN, Boppana VK, Vlasses PH, Rotmensch HH, Ferguson RK. Norfloxacin disposition after sequentially increasing oral doses. Antimicrob Agents Chemother. 1983 Feb; 23(2):284-8. PMID: 6220672.
      Citations:    
    42. Swanson BN, Mojaverian P, Boppana VK, Vlasses PH, Ferguson RK. Dimethyl sulfoxide inhibits metabolic activation of sulindac. Ann N Y Acad Sci. 1983; 411:381-2. PMID: 6576719.
      Citations:    
    43. Mojaverian P, Fedder IL, Vlasses PH, Rotmensch HH, Rocci ML, Swanson BN, Ferguson RK. Cimetidine does not alter morphine disposition in man. Br J Clin Pharmacol. 1982 Dec; 14(6):809-13. PMID: 7150459.
      Citations:    
    44. Goldstein FJ, Mojaverian P, Ossipov MH, Swanson BN. Elevation in analgetic effect and plasma levels of morphine by desipramine in rats. Pain. 1982 Nov; 14(3):279-282. PMID: 7155623.
      Citations:    
    45. Swanson BN, Boppana VK, Vlasses PH, Holmes GI, Monsell K, Ferguson RK. Sulindac disposition when given once and twice daily. Clin Pharmacol Ther. 1982 Sep; 32(3):397-403. PMID: 7049504.
      Citations:    
    46. Ferguson RK, Vlasses PH, Irvin JD, Swanson BN, Lee RB. A comparative pilot study of enalapril, a new converting enzyme inhibitor, and hydrochlorothiazide in essential hypertension. J Clin Pharmacol. 1982 Jul; 22(7):281-9. PMID: 6286734.
      Citations:    
    47. Ferguson RK, Vlasses PH, Swanson BN, Mojaverian P, Hichens M, Irvin JD, Huber PB. Effects of enalapril, a new converting enzyme inhibitor, in hypertension. Clin Pharmacol Ther. 1982 Jul; 32(1):48-53. PMID: 6282527.
      Citations:    
    48. Vlasses PH, Rotmensch HH, Swanson BN, Mojaverian P, Ferguson RK. Low-dose captopril: its use in mild to moderate hypertension unresponsive to diuretic treatment. Arch Intern Med. 1982 Jun; 142(6):1098-101. PMID: 6284081.
      Citations:    
    49. Ferguson RK, Vlasses PH, Swanson BN, Mojaverian P, Koplin JR. Comparison of the effects of captopril, diuretic and their combination in low- and normal-renin essential hypertension. Life Sci. 1982 Jan 04; 30(1):59-65. PMID: 7033708.
      Citations:    
    50. Mojaverian P, Swanson BN, Vlasses PH, Ferguson RK. Potentially lethal interaction of cimetidine and morphine. Can Med Assoc J. 1981 Dec 01; 125(11):1212-3. PMID: 20313642.
      Citations:    
    51. Swanson BN, Mojaverian P, Boppana VK, Dudash MR. Effect of dimethyl sulfoxide on sulindac disposition in rats. Drug Metab Dispos. 1981 Nov-Dec; 9(6):499-502. PMID: 6120805.
      Citations:    
    52. Swanson BN, Hichens M, Mojaverian P, Ferguson RK, Vlasses PH, Dudash M. Angiotensin converting enzyme activity in human serum: relationship to enzyme inhibitor in vivo and in vitro. Res Commun Chem Pathol Pharmacol. 1981 Sep; 33(3):525-36. PMID: 6276950.
      Citations:    
    53. Ferguson RK, Vlasses PH, Swanson BN. Effects of captopril, diuretic, and their combination in low-renin essential hypertension. Life Sci. 1980 Dec 22-29; 27(25-26):2519-22. PMID: 7012509.
      Citations:    
    Swanson's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (220)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _